EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review

Julie-Anne T Matheson iD, R M Damian Holsinger iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Julie-Anne T Matheson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Neuroscience and Dementia, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, …. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Gastrointestinal Microbiome, Microbiota, Clostridium Infections. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government Research Training Program (RTP) Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases are highly prevalent but poorly understood, and with few treatment options despite decades of intense research, attention has recently shifted toward other mediators of neurological disease that may present future targets for therapeutic research. One such mediator is the gut microbiome, which communicates with the brain through the gut–brain axis and has been implicated in various neurological disorders. Alterations in the gut microbiome have been associated with numerous neurological and other diseases, and restoration of the dysbiotic gut has been shown to improve disease conditions. One method of restoring a dysbiotic gut is via fecal microbiota transplantation (FMT), recolonizing the “diseased” gut with normal microbiome. Fecal microbiota transplantation is a treatment method traditionally used for Clostridium difficile infections, but it has recently been used in neurodegenerative disease research as a potential treatment method. This review aims to present a summary of neurodegenerative research that has used FMT, whether as a treatment or to investigate how the microbiome influences pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesGastrointestinal MicrobiomeMicrobiotaClostridium InfectionsHumansFecal Microbiota TransplantationDysbiosis

Stichwörter der Autor:innen

Alzheimer’s diseaseParkinson’s diseaseamyotrophic lateral sclerosisfecal microbiota transplantgut microbiomemultiple sclerosisneurodegenerative disease

Autor:innen und Institutionen

  • Laboratory of Molecular Neuroscience and Dementia, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2050, Australia.
  • Neuroscience, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2006, Australia.

ORCID-Profile: Julie-Anne T Matheson, R M Damian Holsinger

Förderung

  • Australian Government Research Training Program (RTP) Scholarship

Zitieren

APA

Matheson, J. T., & Holsinger, R. M. D. (2023). The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021001

Vancouver

Matheson JT, Holsinger RMD. The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021001

BibTeX
@article{Matheson2023,
  author = {Matheson, Julie-Anne T and Holsinger, R M Damian},
  title = {The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021001}
}
Kostenlos starten →